Drug intelligence / Profile preview

parietaria extract

Development stage
Preclinical
Lead developer
Stallergenes Greer
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual
01

Overview

**Parietaria extract** is an allergen extract prepared from *Parietaria* pollen, used primarily for allergen-specific immunotherapy in patients with *Parietaria*-induced allergic rhinitis, allergic rhinoconjunctivitis, and sometimes allergic asthma. Its therapeutic effect is not based on classical receptor pharmacology; rather, repeated controlled exposure to the relevant pollen allergens is intended to induce immune tolerance, including a shift away from pathogenic IgE-mediated hypersensitivity and toward regulatory and blocking-antibody responses. The term is somewhat non-specific because different commercial products may be derived from different *Parietaria* species such as *Parietaria judaica* or *Parietaria officinalis*, and may be formulated for subcutaneous or sublingual immunotherapy.

Other names
Parietaria extractparietaria judaica extractparietaria officinalis extractpellitory pollen extractParietaria pollen extract
02

Targets

IgE (Immunoglobulin E)γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on parietaria extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on parietaria extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call